Attached herewith Statement of Deviation for quarter ended 30th September, 2026

Date: 07 November 2026 BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai -400001, India Script Code: 543963 ISIN: INE013V01011 Subject: Statement of Deviation or Variation pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Dear Sir/Madam, With reference to subject matter and pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, we hereby confirm that during the half year ended on 30 September 2026 there was no deviation or variation in the utilisation of proceeds of Preferential Issues of Warrants convertible in to Equity Shares from the objects approved in Extraordinary General Meeting held on 23 July 2025. Please find attached herewith the detailed Statement of Deviation or Variation for the half year ended 30th September, 2026 A statement of deviation, stating that there is no deviation or variation in the utilisation of these proceeds, duly reviewed by the Audit Committee of the Company is attached herewith. Please take the above on your records. Thanking You. FOR SHELTER PHARMA LIMITED MUSTAQIM NISARAHMED SABUGAR DIN: 01456841 MANAGING DIRECTOR Encl: As Below Statement of Deviation / Variation in utilisation of funds raised Rs in lakhs Name of listed entity Shelter Pharma Ltd Mode of Fund Raising Public Issues / Rights Issues / Preferential Issues / QIP / Others Amount Raised Rs. 2602.50 (In Lakhs) Date of Raising Fund 06-08-2025 Monitoring Agency Not Applicable Monitoring Agency Name, if applicable Not Applicable Is there a Deviation / Variation in use of No funds raised If yes, whether the same is pursuant to Not Applicable change in terms of a contract or objects, which was approved by the shareholders If Yes, Date of shareholder Approval Not Applicable Explanation for the Deviation / Variation Not Applicable Comments of the Audit Committee after No Comments review Comments of the auditors, if any No Comments Objects for which funds have been raised and where there has been a deviation, in the following table Original Object Modifie Original Modified Funds Amount Remarks d Allocatio allocation Utilised of Object, n , if any (INR in Deviati if any lakhs) on/Vari ation Working Capital N.A 2531.20 N.A 2531.20 N.A There is no requirements deviation in the Objects for utilization of funds General Corporate N.A 71.30 N.A. 71.30 N.A There is no Purposes deviation in the Objects for utilization of funds Total 2602.50 2602.50 Note: Rs. 930.35 lakh received as 25% subscription money on the issue of 88,08,000 warrants at an price of Rs.42.25 per share. Subsequently, Rs.1672.15 lakh received upon conversion on 52,77,000 warrants in to equity shares, representing the balance 75% conversion consideration. Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed (c) Change in terms of a contract referred to in the fund-raising document i.e. prospectus, letter of offer, etc FOR SHELTER PHARMA LIMITED MUSTAQIM NISARAHMED SABUGAR DIN: 01456841 MANAGING DIRECTOR Date: 07 November 2026 +9L77789 06786 AIvi &Associqtes contact@a lviandassociates.com IND CHARTERED ACCOUNTANTS www.a lvia ndassociates.com Board of Directors, Shelter Pharma Limited Shelternagar, Nr.S.T. Bus Stand, Himmatnagar - 383001, Gujarat, India Sub: Report on Statement of Deviation and Varlation on Utillzation of Funds Raised through Preferential Issue of Convertible Warrants into Equity Shares by the Shelter Pharma Limited till SOth Septembet,2026 Management's Responsibility for the Statement The Management of the company is responsible for the preparation of the Annexure. This includes collection, collating and validation of data and presentation thereof in the Annexure and the design, implementation and maintenance of internal control relevant to the preparation of the Annexure that are free from material misstatement, whetJrer due to fraud or error. The Management of the company is also responsible for the maintenance of proper books of account and other records and documents containing relevant details about Deviation and Variation in Utilization of Funds raised through Preferential Issue of Convertible Warrants into Equlty Shares by the company. Auditor's Responsibility Our responsibility, for the purpose of this certificate is limited to certify the information containing in the Annexure on the basis of examination of the books of accounts, Statements and other relevant records and documents for the period ending 30tt September, 2026 maintained by the company and produced before us for verification containing relevant details about the deviation and variation in Utilization of Funds Raised through Preferential Issue of Convertible Warrants into Equity Shares by the company. We conduct our examination of the Annexure in accordance with the Guidance Note on Reports or certificate for Special Purpose (the "Guidance Note") issued by the Institute of Chartered Accountant of India ('ICAI") and Standard on Auditing specilied under Section 143(10) of the companies Act 2013. The Guidance note requires that we comply with the ethical requirements of the Co{e of Ethics issued by the ICAL We have complied with the relevant applicant requirement of the Standards on Quality Control (SQC) Quality control for firms that Performs Audits and reviews of Historical Financial Information, and other Assurance and Related Services Engagements. Opinion On the basis of our examination of books and accounts, statements, other relevant records and documents containing relevant details for the Period ended 30th September, 2026 and according to the information, explanations and representati statements of l)eviation and Variation in Utilization of Funds Preferential Issue of convertible warrants into Equity shares by the FRN: 161053W @ n-r:01, Sun westbank, Nr. Vallabh sada'n Riverfront, Ashram Road, Ahmed annexure(Cumulative working) correctly extracted nts. Annexurree statement of Deviation and variation on utilization of Funds Sr. Object Amount Actual Un Remarkr No. disclosed in received for Utllized Utillzed the Notice obJect Amount Amount dated (Rs in (Rs in (Rs in 26tr, June Lakhsf Lakhs) Lakhs) 2o2s (*) 1. Working Capital 2531.20 2531.20 There is n Requirements deviation the Object for utilizatic n of funds 2 General 71.30 71.30 There is n Corporate deviation Purposes the Object for utilizatic 1 of funds Total 2602.50 2602.50 (*)Rs. 993300..3355 lakh received as 25% subscription money on the issue of g ,08,000 warranLttss aatt aan price of Rs.42.25 per share. subsequently, Rs.1672.15 lakh received upon c;oonnvveerrssiion on 52,77,o00 warrants in to equity shares, representing the balance 757o co;nnvveerrssiioon consideration. For Alvi && AAssssoocciiaatled, Charteregdd AAccccoouunnttants Firm Reggiissttrraattiioonn No. 16lO53W -'rl* CA Aasim ef*ri (Partne)rr)) M. NO: 6622587a UDIN:2266(625878FCKSQG1542 Place: AAhhrmedabad Date:O77 /l7LL12026